Abstract
The pineal hormone melatonin has been shown to have anticancer therapeutic properties in patients with gastric cancer, the mechanisms, however, remain largely unknown. The present study examined the effects of melatonin on cell differentiation related factors, namely, endocan, alkaline phosphatase, and lactate dehydrogenase, in gastric adenocarcinoma cell line SGC7901. Expression of endocan was significantly decreased in tissue of gastric cancer as compared to normal stomach tissue, as determined by immunohistochemical staining, and there is correlation between the degree of the decrease of endocan expression and the degree of differentiation of the cancer. Treatment of cultured gastric adenocarcinoma cells with 10−4 mol/l melatonin significantly increased the gene expression of endocan and down-regulated the activity of alkaline phosphatase and lactate dehydrogenase, two enzymes that promote de-differentiation in gastric tissue; and there was a negative correlation between the level of endocan expression and the activities of differentiation marker enzymes in the melatonin treated cancer cells. Gastric cancer cells treated with melatonin show more differentiated morphologic phenotype as compared the untreated cells. The findings indicate that melatonin may play its anticancer role in gastric adenocarcinoma by acting as a differentiation inducer.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W (2009) PARP-1 Val762Ala polymorphism, CagA + H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 36:1461–1467
Hou R, Cao B, Chen Z, Li Y, Ning T, Li C, Xu C, Chen Z (2010) Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep 37:515–520
Lissoni P, Brivio F, Ardizzoia A, Tancini G, Barni S (1993) Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance status. Tumori 79:401–404
Alberti C (1958) Melatonin: the first hormone isolated from the pineal body. Farmaco Sci 13:604–605
Berra B, Rizzo AM (2009) Melatonin: circadian rhythm regulator, chronobiotic, antioxidant and beyond. Clin Dermatol 27:202–209
Cardinali DP, Esquifino AI, Srinivasan V, Pandi-Perumal SR (2008) Melatonin and the immune system in aging. Neuroimmunomodulation 5:272–278
Ambriz-Tututi M, Rocha-González HI, Cruz SL, Granados-Soto V (2009) Melatonin: a hormone that modulates pain. Life Sci 84:489–498
Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP (2009) Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci 119:821–846
Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ, Viswanathan M, Zisapel N (1998) Prospects of the clinical utilization of melatonin. Biol Signals Recept 7:195–219
Lissoni P, Barni S, Tancini G, Ardizzoia A, Rovelli F, Cazzaniga M, Brivio F, Piperno A, Aldeghi R, Fossati D (1993) Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract. Br J Cancer 67:1404–1407
Lissoni P, Brivio F, Fumagalli L, Messina G, Vigoré L, Parolini D, Colciago M, Rovelli F (2008) Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Anticancer Res 28:1377–1381
Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andrés O, González P, González-Gallego J (2008) Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 45:532–540
Korkmaz A, Tamura H, Manchester LC, Ogden GB, Tan DX, Reiter RJ (2009) Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line. J Pineal Res 46:115–116
Bechard D, Gentina T, Delehedde M, Scherperee Al, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, Janin A, Fernig DG, Tonnel AB, Lassalle P (2001) Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 276:48341–48349
Béchard D, Scherperee Al, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, Pestel J, Dessaint JP, Tonnel AB, Lassalle P (2001) Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 167:3099–3106
Chen LY, Liu X, Wang SL, Qin CY (2010) Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res 38:498–510
Perey L, Benhattar J, Peters R, Jaunin P, Leyvraz S (2001) High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR. Br J Cancer 85:1713–1721
Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P (2010) Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 56:80–187
Maurage CA, Adam E, Minéo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M (2009) Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol 68:633–641
Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB, Lassalle P (2006) Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res 12:4575–4582
Huang GW, Tao YM, Ding X (2009) Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci 54:389–394
Zuo L, Zhang SM, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q, Wang Y (2008) Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol 14:4562–4568
Herz F, Halwer M (1990) Differential effects of sodium butyrate and hyperosolality on the modulation of alkaline phosphatases of LoVo cells. Exp Cell Res 188:50–54
Honma Y, Takenaga K, Kasukabe T, Hozumi M (1980) Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun 95:507–512
Fishman WH (1992) Recent developments in alkaline phosphatase research. Clin Chem 38:2484
Carda-Abella P, Perez-Cuadrado S, Lara-Baruque S, Gil-Grande L, Nuñez-Puertas A (1982) LDH isoenzyme patterns in tumors, polyps, and uninvolved mucosa of human cancerous colon. Cancer 49:80–83
Nowak G, Griffin JM, Schnellmann RG (1996) Hypoxia and proliferation are primary responsible for induction of lactate dehydrogenase activity in cultured cells. J Toxicol Environ Health 46:439–452
Acknowledgments
This study was supported by Natural Science Foundation of Anhui Province (No. 090413116) and National Natural Science Foundation of China (No. 30971226).
Author information
Authors and Affiliations
Corresponding author
Additional information
Sumei Zhang and Li Zuo contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, S., Zuo, L., Gui, S. et al. Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 39, 2843–2849 (2012). https://doi.org/10.1007/s11033-011-1043-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-1043-4